EN DE
Watch Bullfrog AI Holdings for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Bullfrog AI Holdings (BFRG) fair value: what the stock is really worth

As of Oct 30, 2026: fair value (intrinsic value) of Bullfrog AI Holdings stock $0.09, price $0.49, upside -82.6%, quality 26 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · ISIN US12021E1091

BA Bullfrog AI Holdings logo Thin data Oct 30, 2026

Bullfrog AI Holdings

BFRG · US
Very expensive, weak quality

Our calculation puts a fair price 83% below what the stock costs today.

Mixed Growth (revenue 3y +126.8 %/yr in USD)
Fair value $0.0850 · Strongly overvalued (−82.6%)
Quality 26/100
Negative free cash flow
Trails peers (1/6)
Narrow moat 23/100 · thin data
Thin data
⚠ Dilution

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$8.74 $0.4285 Fair Value $0.0850 Jan 2023 Oct 2026

White line = price, green steps = our fair value per fiscal year. As of Oct 30, 2026.

How to read this chart

45‑month range $0.4285 – $8.74 · fair‑value band $0.0595 – $0.1105 · the $0.4877 price screens above the $0.0850 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 30, 2026.

Follow Bullfrog AI in your weekly email

Every Wednesday you see whether Bullfrog AI is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.

Show moreShow less

The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations.

It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases.

The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease.

It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.

Stock analysis

Bullfrog AI Holdings (BFRG) currently trades at $0.4877, while our model-based Fair Value estimate is $0.0850, 82.6% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: $0.0595 (bear) to $0.1105 (bull), the price of $0.4877 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 26/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Bullfrog AI Holdings reported revenue of $117K in FY2025 versus $0 in FY2021. Reported net income was −$6.5M in FY2025.

Key figures

Market cap $9.0M Micro · P/S ratio 40.1 · EPS (TTM) $−0.4600 · Return on equity −131% · Return on assets (EBIT) −1,832% · Operating margin −659% · Revenue (TTM) $299K · Revenue growth (YoY) +548%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (low confidence).

What moves the price

The share trades about 71% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 4% fair-value upside, at −83%, BFRG screens richer than that median.

Fair Value models

Bear $0.0595 Fair Value $0.0850 Bull $0.1105
Price $0.4877 · Upside -82.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) $0.0700 $0.1000 $0.1300 52
All 1 models by family
Asset-Based
NCAV (Graham) $0.0700 $0.1000 $0.1300 52

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 26/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 35
Are margins and returns getting better?
Cashflow 8
Do the profits arrive as real cash?
Financial strength 66
Debt, balance sheet and risk of trouble
Investment 50
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Momentum 10
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 30/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

BFRG screens overvalued: fair value 83% below the price. Compare with Veeva Systems Inc →

Compare Bullfrog AI Holdings with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 123 stocks

Beats the industry median on 1/5 measures
Overall it trails its industry peers.
Valuation
Quality Score 26 · Bottom 25%
Fair Value upside −82.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 547.6% · Top 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 4.23× · Priciest 25%
P/S (12 months) 30.26× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 4
FUTURE (revenue growth)100 · sector 40
PAST (return on equity)0 · sector 9
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 38

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Veeva Systems Inc VEEV $310.34 $341.37 +10% vs BFRG
HealthEquity, Inc HQY $101.36 $111.50 +10% vs BFRG
Doximity, Inc DOCS $34.25 $37.68 +10% vs BFRG
Inventurus Knowledge Solutions Limited IKS ₹1,703 ₹1,873 +10% vs BFRG
Waystar Holding WAY $28.02 $29.10 +4% vs BFRG
Winning Health Technology Group 300253 ¥7.10 ¥3.44 −52% vs BFRG
Hinge Health, Inc HNGE $113.90 $51.25 −55% vs BFRG
BrightSpring Health Services, Inc BTSG $58.36 $25.86 −56% vs BFRG
Pro Medicus Limited PME A$196.00 A$85.12 −57% vs BFRG
Privia Health Group PRVA $22.00 $5.52 −75% vs BFRG

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Bullfrog AI Holdings Fair Value". https://www.fairvalue-calculator.com/stock/BFRG

Frequently asked questions

Is Bullfrog AI Holdings (BFRG) overvalued or undervalued?
As of Oct 30, 2026, our model estimates a fair value of $0.0850 versus a price of $0.4877, about −83% upside (overvalued).
What is the fair value of BFRG?
Our model-based fair value for Bullfrog AI Holdings is $0.0850 (as of Oct 30, 2026), built from audited fundamentals. The current price: $0.4877.
What is the quality score of BFRG?
Bullfrog AI Holdings has a Quality Score of 26/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bullfrog AI Holdings (BFRG)?
Our model-based price target is the fair value of $0.0850 (as of Oct 30, 2026) from 1 valuation models. Cautious scenario $0.0595, optimistic scenario $0.1105. It is a calculation from audited fundamentals, not an analyst target.
What is the Bullfrog AI Holdings stock forecast for 2026?
Our models put fair value at $0.0850, about −83% upside versus a price of $0.4877 (overvalued). Cautious scenario $0.0595, optimistic scenario $0.1105. The calculation is refreshed regularly with new filings.
What is the revenue of Bullfrog AI Holdings (BFRG)?
Bullfrog AI Holdings reported trailing-twelve-month revenue of about $299K (latest available figure, as of Oct 30, 2026).
What is the intrinsic value of Bullfrog AI Holdings (BFRG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bullfrog AI Holdings it is $0.0850 per share (as of Oct 30, 2026), against a price of $0.4877. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Bullfrog AI Holdings stock overvalued or undervalued in 2026?
As of Oct 30, 2026, BFRG trades above its calculated fair value: price $0.4877, fair value $0.0850, a gap of about −83% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BFRG?
No. The price is what the market pays today ($0.4877); the fair value is what the company's own numbers justify ($0.0850). For Bullfrog AI Holdings the two are $0.4027 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bullfrog AI Holdings worth?
The market values Bullfrog AI Holdings at about $9.0M (market capitalisation, as of Oct 30, 2026). Per share that is $0.4877; our models calculate a fair value of $0.0850 per share.
What do the bullish and bearish scenarios say about BFRG?
Our models span a range for Bullfrog AI Holdings: cautious scenario $0.0595, base $0.0850, optimistic $0.1105 per share (as of Oct 30, 2026, price $0.4877). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Bullfrog AI Holdings (BFRG)?
Balance-sheet figures for Bullfrog AI Holdings (as of Oct 30, 2026): return on equity −130.7%. They feed the Quality Score of 26/100, which measures business quality independently of the share price.
How far is BFRG from its 52-week high?
Bullfrog AI Holdings trades at $0.4877, about 71% below its 52-week high of $1.68 and 14% above the low of $0.4285 (as of Oct 30, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0850 is for.
Which stocks are comparable to Bullfrog AI Holdings?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bullfrog AI Holdings stock attractive at the current price?
The data as of Oct 30, 2026: price $0.4877, calculated fair value $0.0850 (−83%), Quality Score 26/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BFRG calculated?
We run Bullfrog AI Holdings through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0850, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. Bullfrog AI Holdings itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bullfrog AI Holdings (BFRG)?
The closing price on Oct 30, 2026 was $0.4877. Our model-based fair value is $0.0850, about −83% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bullfrog AI Holdings right now?
The price sits above even our optimistic bull case ($0.1105). The favourable scenario is already priced in. Weak quality (26/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.0595 to $0.1105) leaves room in how you read the outcome.

Key figures of Bullfrog AI Holdings

How large is the market capitalisation of Bullfrog AI Holdings (BFRG)?
The market capitalisation of Bullfrog AI Holdings is $9.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bullfrog AI Holdings (BFRG)?
The price-to-sales ratio of Bullfrog AI Holdings is 40.1 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Bullfrog AI Holdings (BFRG)?
Earnings per share at Bullfrog AI Holdings are $−0.4600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Bullfrog AI Holdings (BFRG)?
The return on equity (ROE) of Bullfrog AI Holdings is −131% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bullfrog AI Holdings (BFRG)?
On an EBIT basis the return on assets of Bullfrog AI Holdings is −1,832% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bullfrog AI Holdings (BFRG)?
The operating margin of Bullfrog AI Holdings is −659% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bullfrog AI Holdings (BFRG)?
Revenue at Bullfrog AI Holdings is growing +548% versus a year earlier (3y avg +127%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Bullfrog AI Holdings (BFRG) generate?
The free cash flow of Bullfrog AI Holdings is −$5.5M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Bullfrog AI Holdings (BFRG) hold?
Bullfrog AI Holdings holds more cash than debt, $2.2M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Bullfrog AI Holdings in the live analysis

One click puts Bullfrog AI Holdings on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.